NeoStem acquires Amorcyte - MarketLine Financial Deals

NeoStem acquires Amorcyte

NeoStem acquires Amorcyte - MarketLine Financial Deals
NeoStem acquires Amorcyte
Published Oct 14, 2011
3 pages — Published Oct 14, 2011
Price US$ 20.00  |  Buy this Report Now

About This Report


NeoStem, Inc., a biopharmaceutical company, has acquired Amorcyte, Inc., a development stage cellular therapies company focused on developing novel treatments for cardiovascular disease.

Document ID
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author

Cite this Report

MarketLine Financial Deals. "NeoStem acquires Amorcyte" Oct 14, 2011. Alacra Store. Jun 25, 2018. <>
MarketLine Financial Deals. (2011). NeoStem acquires Amorcyte Oct 14, 2011. New York, NY: Alacra Store. Retrieved Jun 25, 2018 from <>
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.